Navigation Links
Consorta Receives Practice Greenhealth Champion for Change Award for Sixth Consecutive Year
Date:5/22/2009

SCHAUMBURG, Ill., May 22 /PRNewswire/ -- Consorta, a leading healthcare group purchasing and resource management organization, announced today that they have received the Practice Greenhealth Champion for Change Award for outstanding contributions to environmentally responsible healthcare. Consorta was presented the award at the Practice Greenhealth Environmental Excellence Awards, held in conjunction with CleanMed 2009, the premier Global Conference on Environmentally Sustainable Health Care.

Consorta was recognized for its continuous support of the goals of Practice Greenhealth. Practice Greenhealth is a landmark initiative to improve the environmental performance of the healthcare industry. This is the sixth consecutive year Consorta has been recognized for its ongoing successful efforts to help its member healthcare facilities reduce their collective impact on the environment and improve the health of the communities they serve.

"Consorta has long been the leader in environmentally preferable purchasing and receiving this award for the sixth consecutive year affirms the leadership role we has taken in greening healthcare," said Darrel Weatherford, president and CEO of Consorta. "We were the first healthcare GPO to introduce a searchable database of environmentally preferable products. Plus, we continue to work closely with suppliers to educate them on the need to eliminate potentially dangerous content from the manufacturing process, as well as work toward good waste minimization practices."

Laura Wenger, director of Clinical Integration for Consorta, who oversees the organization's environmental initiatives, added, "Consorta continues to work to find environmentally-friendly alternatives for our members through advocacy, education, contracting disclosures, and the development of environmentally preferable purchasing and chemical policies. We will continue to work closely with HealthTrust Purchasin
'/>"/>

SOURCE Consorta, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Consorta Board Appoints Darrel Weatherford President and Chief Executive Officer
2. Christopher & Dana Reeve Foundation Receives $25,000 Gift from TD Bank
3. Go Healthy Receives Letter of Endorsement from the Texas Chiropractic Association, District Five State Director - Dr. Thomas Klesmit
4. Broadlane Receives Environmental Award for Excellence
5. The Club at Briarcliff Manor Receives Certificate of Authority from New York
6. CareTech Receives National Recognition in 2009 Aster Awards for Medical Marketing Excellence
7. Author Mary Soliel Receives Third National Book Award for Debut Non-Fiction on Synchronicity
8. Cardiva Medical, Inc. Receives FDA Clearance for the Catalyst(TM)III System, First in Class Drug Coated Vessel Closure Device
9. Gentiva(R) Health Services Receives Nasdaq Notification Regarding Independent Director Requirement
10. SCM Microsystems Upgradable Mobile Terminal eHealth500 Receives Certification for German eHealth Program
11. BioMarin Receives 2009 Corporate Award for the Development of Kuvan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2009)... Allows Consolidated Access to Interdisciplinary Evidence-based Content throughout the ... ... (PRWEB) December 7, 2009 -- Institutions currently using ... and Zynx Health will benefit from a ... their evidence-based resources, resulting in quicker retrieval of relevant ...
(Date:12/7/2009)... collection agency A.R.M. Solutions was recognized as a leader in ... Solutions, award-winning recovery service outperforms traditional collection agencies in speed, ... ... (PRWEB) December 7, 2009 -- A.R.M. Solutions, a leading provider ... Best Places to Work in Collections by insideARM.com. This is ...
(Date:12/7/2009)... discovered a technique that is able to determine whether ... snoring by screening their urine. , "These findings ... urine test that could detect OSA in snoring children. ... sleep studies in children who snore, only about 20 ... lead author David Gozal, M.D., professor and chairman of ...
(Date:12/6/2009)... San Antonio Bay ,, SILVER SPRING, Md., Dec. ... is advising consumers to avoid eating oysters harvested from ... due to reports of norovirus-associated illnesses in some people ... is located on the Gulf of Texas. ,, ... along with the Centers for Disease Control and Prevention ...
(Date:12/6/2009)... in virus , , SUNDAY, Dec. 6 (HealthDay News) -- Early ... in a tiger that lived thousands or millions of years ... took on a bit of a tiger,s genetic material, scientists ... virus to this day. That tiger, in fact, may have ... that ultimately led to its infection of humans. , The ...
Breaking Medicine News(10 mins):Health News:EBSCO Publishing and Zynx Health Expand Partnership for Integrated Access to Evidence-Based Content 2Health News:EBSCO Publishing and Zynx Health Expand Partnership for Integrated Access to Evidence-Based Content 3Health News:Collection Agency Named One of 2009 Best Places to Work 2Health News:Urine test for pediatric obstructive sleep apnea possible 2Health News:FDA, CDC, and States Investigating Norovirus Illnesses Linked to Oysters 2Health News:AIDS May Date Back to Ancient Tiger 2
... announced on Tuesday that the city has experienced a 37% ... new cases reported// in the first three months of the ... under the Department of Health, which filed the statistics on ... contact. Reviewing the AIDS situation in Hong Kong at a ...
... sudden demise of the Director General of World Health Organization, ... programmes, People's Health Organization (India) said here today.// ,Lee, ... and other deadly diseases, was the first WHO chief to ... S Gilada said., ,PHO's condolence resolution stated that "the ...
... provides protection against flu to the elderly people,// but ... without any major harmful effect. This was published in ... a JAMA/Archives journal. ,Vaccines containing inactivated influenza virus ... and its complications, according to background information in the ...
... distributing condoms in the province would no longer be able ... teenage pregnancies//. The trust said that only authorized staff could ... ,"My concern is that child protection is ... Dean Marshall, deputy chairman of the BMA's Scottish GP committee. ...
... suffer from disrupting sleep and increased blood pressure. But ... breathing masks are very helpful// in giving them an ... pressure significantly. ,The study results were presented at ... have significant consequences on a person's physical health, and ...
... it was found that amino acid, l-cysteine can prevent ... of the cancers occur// in the mouth, pharynx and ... drinking. This results in a strong exposure of the ... research group of Professor Mikko Salaspuro, University of Helsinki ...
Other Medicine News:Health News:Immunity carefully enhanced in elders by high-dose flu vaccines 2Health News:Sleep Apnea Patients Benefit from Breathing Mask 2Health News:Finnish research: Cysteine Chewing Gum as a cure for cancers of the mouth 2
(Date:12/4/2009)... Inc. (NYSE Amex: PIP ), a biodefense company ... today the presentation of new data from the Company,s ... Antigen (rPA) based anthrax vaccine is structurally stable and ... and including 55 degrees C. The data were ...
(Date:12/4/2009)... PharmAthene, Inc. (NYSE Amex: PIP ), ... and chemical threats, announced today that the Company ... effectiveness of Valortim® in an inhalation anthrax model ... The data are being presented during an oral ...
(Date:12/4/2009)... 4 Watson Pharmaceuticals, Inc. (NYSE: WPI ... that its subsidiary, Watson Laboratories, Inc.-Florida, filed an Abbreviated ... Drug Administration seeking approval to market its 8mg ramelteon ... by Takeda Pharmaceutical Company Limited. Watson,s 8mg ramelteon ...
Breaking Medicine Technology:PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Janet Sartin Expands Line of Products That Reduce and Conceal Eye Puffiness and Fine Lines 51168 1Janet Sartin Expands Line of Products That Reduce and Conceal Eye Puffiness and Fine Lines 51168 2Janet Sartin Expands Line of Products That Reduce and Conceal Eye Puffiness and Fine Lines 51168 3ONRAD Announces New PACS Application Service Provider Model 51165 1ONRAD Announces New PACS Application Service Provider Model 51165 22 reproductive factors are important predictors of death from ovarian cancer 9184 12 reproductive factors are important predictors of death from ovarian cancer 9184 22 reproductive factors are important predictors of death from ovarian cancer 9184 3
... 04, 2007 /PRNewswire-FirstCall/ --,Genta Incorporated announced the ... trial of its marketed product, Ganite(R) (gallium,nitrate ... patients with relapsed or refractory non-Hodgkin's,lymphoma (NHL). ... meeting of,the American Society of Clinical Oncology ...
... Pertuzumab shows promising results in,advanced breast cancer ... BASEL, Switzerland, June 4, 2007-Early clinical results ... medicine pertuzumab, a HER,dimerisation inhibitor, show substantial ... breast cancer, when,combined with Herceptin. The study ...
Other Medicine Technology:Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 2Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 3Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 4Phase 2 Clinical Results of Ganite Plus Standard Therapy in,Patients with Relapsed/Refractory Lymphoma Presented at ASCO 5Investigational Cancer Drug Pertuzumab Shows Promising Results in,Advanced Breast Cancer When Combined with Herceptin 2Investigational Cancer Drug Pertuzumab Shows Promising Results in,Advanced Breast Cancer When Combined with Herceptin 3Investigational Cancer Drug Pertuzumab Shows Promising Results in,Advanced Breast Cancer When Combined with Herceptin 4Investigational Cancer Drug Pertuzumab Shows Promising Results in,Advanced Breast Cancer When Combined with Herceptin 5
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 8.0 mm and length 8 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 9.0 mm and length 10 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 19.0 mm and length 21 mm....
... The BacT/Alert 3D Signature is ... microbial detection system that integrates blood, ... It is a powerful microbiology workstation ... for higher volume identification and where ...
Medicine Products: